A Trial Investigating the Pharmacodynamics of BC Combo THDB0207 Compared With Humalog® Mix25 and Simultaneous Injections of Humalog® and Lantus® in Healthy Chinese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 12, 2022

Primary Completion Date

December 4, 2022

Study Completion Date

December 4, 2022

Conditions
Healthy
Interventions
DRUG

Euglycemic clamp with BC Combo THDB0207

Administration of a single dose of BC Combo THDB0207 during an euglycemic clamp procedure

DRUG

Euglycemic clamp with Humalog® Mix25

Administration of a single dose of Humalog® Mix25 during an euglycemic clamp procedure

DRUG

Euglycemic clamp with Humalog® and Lantus®

Simultaneous administration of Humalog® and Lantus® during an euglycemic clamp procedure

Trial Locations (1)

41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Tonghua Dongbao Pharmaceutical Co.,Ltd

INDUSTRY

lead

Adocia

INDUSTRY